MBS8400241 | Anti-IL-23alpha (Tildrakizumab); Humanized Antibody

(No reviews yet) Write a Review
Usually Shipped in 5 Working Days
AUD659.00 - AUD2,782.00
Frequently bought together:


Anti-IL-23alpha (Tildrakizumab); Humanized Antibody | MBS8400241 | Mybiosource

Product Short Name: [IL-23alpha]

Product Name Synonyme: [MK-3222; SCH 900222; P19; SGRF; IL-23; IL23A; IL23P19]

Other Names: N/A

Product Gene Name: [IL-23alpha]

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG1; kappa

Clone: N/A

Host: Human

Reactivity: Human

Specificity: The biosimilar is a humanized monoclonal antibody that specifically targets IL-23 p19 subunit and inhibits the release of cytokines and chemokines involved in mediating inflammation in psoriasis

Purity: Protein A purified

Form: Colorless liquid. In PBS; pH7.5

Concentration: 1mg/ml

Storage Stability: Store at -80 degree C. The antibody solution should be gently mixed before use.
Shipping: Gel Pack
Shelf Life: Est.~12 months
Country of Origin: USA

Tested Application: N/A

View AllClose